LI-CYCLE HOLDINGS CORP (LICY)

CA50202P2044 - Common Stock

2.08  -0.03 (-1.42%)

After market: 2.0511 -0.03 (-1.39%)

Fundamental Rating

1

LICY gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of LICY have multiple concerns. LICY is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

LICY had negative earnings in the past year.
LICY had negative earnings in each of the past 5 years.
In the past 5 years LICY always reported negative operating cash flow.

1.2 Ratios

LICY has a worse Return On Assets (-15.85%) than 86.90% of its industry peers.
LICY's Return On Equity of -46.73% is on the low side compared to the rest of the industry. LICY is outperformed by 80.95% of its industry peers.
Industry RankSector Rank
ROA -15.85%
ROE -46.73%
ROIC N/A
ROA(3y)-18.57%
ROA(5y)N/A
ROE(3y)-33.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LICY does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

LICY does not have a ROIC to compare to the WACC, probably because it is not profitable.
LICY has more shares outstanding than it did 1 year ago.
LICY has a better debt/assets ratio than last year.

2.2 Solvency

LICY has an Altman-Z score of -1.19. This is a bad value and indicates that LICY is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LICY (-1.19) is worse than 86.90% of its industry peers.
LICY has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.16, LICY is doing worse than 69.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z -1.19
ROIC/WACCN/A
WACC5.39%

2.3 Liquidity

A Current Ratio of 0.60 indicates that LICY may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.60, LICY is doing worse than 92.86% of the companies in the same industry.
LICY has a Quick Ratio of 0.60. This is a bad value and indicates that LICY is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.54, LICY is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.54

6

3. Growth

3.1 Past

LICY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.64%, which is quite impressive.
Looking at the last year, LICY shows a very strong growth in Revenue. The Revenue has grown by 36.57%.
Measured over the past years, LICY shows a very strong growth in Revenue. The Revenue has been growing by 185.06% on average per year.
EPS 1Y (TTM)25.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%241.45%
Revenue 1Y (TTM)36.57%
Revenue growth 3Y185.06%
Revenue growth 5YN/A
Sales Q2Q%-6.38%

3.2 Future

The Earnings Per Share is expected to decrease by -44.14% on average over the next years. This is quite bad
The Revenue is expected to grow by 107.75% on average over the next years. This is a very strong growth
EPS Next Y-271.44%
EPS Next 2Y-76.95%
EPS Next 3Y-44.14%
EPS Next 5YN/A
Revenue Next Year83.33%
Revenue Next 2Y47.18%
Revenue Next 3Y38.43%
Revenue Next 5Y107.75%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LICY. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LICY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as LICY's earnings are expected to decrease with -44.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-76.95%
EPS Next 3Y-44.14%

0

5. Dividend

5.1 Amount

No dividends for LICY!.
Industry RankSector Rank
Dividend Yield N/A

LI-CYCLE HOLDINGS CORP

NYSE:LICY (11/21/2024, 7:37:26 PM)

After market: 2.0511 -0.03 (-1.39%)

2.08

-0.03 (-1.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap48.30M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.85%
ROE -46.73%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.6
Quick Ratio 0.54
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)25.64%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-271.44%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)36.57%
Revenue growth 3Y185.06%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y